Of these, 35 were preclinical animal studies and only one represented a human clinical investigation
In this article, we will conclude with the potential pharmacological mechanisms of GLP-1 treatment for MASLD, including clinical insights into GLP-1RAs and co-agonist drugs
Prysyazhnyuk V, Sydorchuk L, Sydorchuk R et al (2021) Glutathione-S-transferases genes-promising predictors of hepatic dysfunction
This aligns with a landmark 2014 study by David et al
By reducing gluconeogenesis, semaglutide further supports the bodys ability to maintain healthy blood sugar levels, which is crucial for weight management and overall metabolic health
In this landscape, Wegovy has emerged as a promising addition to our arsenal of obesity treatments